“…[1,2] It causes infections similar to those triggered by S aureus, including skin and soft tissue infections, respiratory infections, necrotizing fasciitis, bone and joint infection, endocarditis, aortic mycotic aneurysm, bacteremia and sepsis, and food poisoning. [13][14][15][16] After the first report of genetically divergent ST75 in Australia in 2002, S argenteus were increasingly reported globally, including Cambodia, Trinidad and Tobago, New Zealand, Fiji, France, Thailand, China, Belgium, Laos, Japan, Denmark, Myanmar, Sweden, Taiwan, German, Nigeria, Canada and the United States, England, and Brazil. [13,17,18] Chen et al reported that compared with patients with methicillin-susceptible S aureus (MSSA) bacteremia, patients with S argenteus bacteremia had a higher percentage of polymicrobial blood culture results (P = .047), prior healthcare-associated exposure within the past year (P = .026), recent hospitalization within 3 months (P = .027), thrombocytopenia (P = .027), and the respiratory tract as the primary focus of infection (P = .028).…”